Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business"
- PMID: 17989174
- PMCID: PMC2268479
- DOI: 10.1128/JVI.01634-07
Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business"
Figures
Similar articles
-
Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine.Am J Hematol. 1996 Oct;53(2):116-7. doi: 10.1002/(SICI)1096-8652(199610)53:2<116::AID-AJH9>3.0.CO;2-2. Am J Hematol. 1996. PMID: 8892736
-
DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults.Clin Vaccine Immunol. 2012 May;19(5):649-58. doi: 10.1128/CVI.00038-12. Epub 2012 Mar 7. Clin Vaccine Immunol. 2012. PMID: 22398243 Free PMC article. Clinical Trial.
-
Developing DNA vaccines against immunodeficiency viruses.Curr Top Microbiol Immunol. 1998;226:161-73. doi: 10.1007/978-3-642-80475-5_10. Curr Top Microbiol Immunol. 1998. PMID: 9479841 Review. No abstract available.
-
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.J Virol. 1998 Dec;72(12):10180-8. doi: 10.1128/JVI.72.12.10180-10188.1998. J Virol. 1998. PMID: 9811759 Free PMC article.
-
[Polynucleotide (DNA) viral vaccines and their safety problems].Zh Mikrobiol Epidemiol Immunobiol. 1997 Jan-Feb;(1):78-81. Zh Mikrobiol Epidemiol Immunobiol. 1997. PMID: 9221666 Review. Russian. No abstract available.
Cited by
-
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.J Gen Virol. 2011 Jan;92(Pt 1):128-40. doi: 10.1099/vir.0.023242-0. J Gen Virol. 2011. PMID: 21169215 Free PMC article.
-
Prospects for control of emerging infectious diseases with plasmid DNA vaccines.J Immune Based Ther Vaccines. 2009 Sep 7;7:3. doi: 10.1186/1476-8518-7-3. J Immune Based Ther Vaccines. 2009. PMID: 19735569 Free PMC article.
-
Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity.Blood. 2009 Jun 4;113(23):5868-77. doi: 10.1182/blood-2008-11-190520. Epub 2009 Mar 20. Blood. 2009. PMID: 19304955 Free PMC article.
-
Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.Vaccine. 2010 Feb 23;28(8):1942-51. doi: 10.1016/j.vaccine.2009.10.095. Vaccine. 2010. PMID: 20188250 Free PMC article.
-
Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.Hum Gene Ther. 2009 Oct;20(10):1143-56. doi: 10.1089/hum.2009.025. Hum Gene Ther. 2009. PMID: 19530914 Free PMC article.
References
-
- Abbink, P., A. A. Lemckert, B. A. Ewald, D. M. Lynch, M. Denholtz, S. Smits, L. Holterman, I. Damen, R. Vogels, A. R. Thorner, K. L. O'Brien, A. Carville, K. G. Mansfield, J. Goudsmit, M. J. Havenga, and D. H. Barouch. 2007. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 814654-4663. - PMC - PubMed
-
- Abimiku, A. G., G. Franchini, J. Tartaglia, K. Aldrich, M. Myagkikh, P. D. Markham, P. Chong, M. Klein, M. P. Kieny, E. Paoletti, et al. 1995. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nat. Med. 1321-329. - PubMed
-
- Aguiar, J. C., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, J. B. Sacci, Jr., D. E. Lanar, V. F. Majam, R. R. Stout, and S. L. Hoffman. 2001. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20275-280. - PubMed
-
- Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 39286-89. - PubMed
-
- Alpar, H. O., S. Somavarapu, K. N. Atuah, and V. W. Bramwell. 2005. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev. 57411-430. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources